Literature DB >> 9596380

Syringe exchange in Canada: good but not enough to stem the HIV tide.

C A Hankins1.   

Abstract

This article provides a historical perspective on the development of syringe exchange in Canada, the Canadian legal and policy context, evaluation and monitoring strategies, and current challenges facing HIV prevention efforts among injecting drug users. Despite the fact that it is legal to sell, exchange, or provide an IDU with a syringe and there are no laws in Canada requiring a physician's prescription to justify possession of a syringe, policy development and programming have not been adequate to hold HIV at bay in several cities across the country. Although there have been concerted efforts by syringe and needle exchange programs to increase the supply of injecting equipment, HIV prevalence continues to rise, provoking a rethinking of the role of syringe exchange. In a coordinated strategy for HIV prevention among drug users in Canada, needle and syringe exchange is not itself in question; however, ghettoization and needle quota systems may have had an adverse impact on prevention programming. A national action plan has been developed which aims to decentralize both methadone maintenance and syringe and needle exchange programs, increase access to detoxification and treatment modalities, and advocate for changes in the criminal justice system and law enforcement practices.

Entities:  

Mesh:

Year:  1998        PMID: 9596380     DOI: 10.3109/10826089809062211

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  16 in total

1.  Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

Authors:  B Fischer; J Rehm; T Blitz-Miller
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Substance use: time for drug law reform.

Authors:  C Hankins
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

4.  Hospital- versus community-based syringe exchange: a randomized controlled trial.

Authors:  Carmen L Masson; James L Sorensen; David C Perlman; Michael S Shopshire; Kevin L Delucchi; TeChieh Chen; Karl Sporer; Don Des Jarlais; Sharon M Hall
Journal:  AIDS Educ Prev       Date:  2007-04

5.  Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.

Authors:  Lucas Wiessing; Giedrius Likatavicius; Danica Klempová; Dagmar Hedrich; Anthony Nardone; Paul Griffiths
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

6.  Organizational issues in the implementation of a hospital-based syringe exchange program.

Authors:  Carmen L Masson; James L Sorensen; Nina Grossman; Karl A Sporer; Don C Des Jarlais; David C Perlman
Journal:  Subst Use Misuse       Date:  2010-05       Impact factor: 2.164

7.  My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.

Authors:  Traci C Green; Catherine A Hankins; Darlène Palmer; Jean-François Boivin; Robert Platt
Journal:  Can J Public Health       Date:  2004 Mar-Apr

8.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

9.  Injecting drugs in tight spaces: HIV, cocaine and collinearity in the Downtown Eastside, Vancouver, Canada.

Authors:  Daniel Ciccarone; Philippe Bourgois
Journal:  Int J Drug Policy       Date:  2016-03-08

10.  The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.

Authors:  Danya Fast; Will Small; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2008-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.